16 participants
Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-13
- Start Date:
- 2026-08-20
- Completion:
- 2027-09-01
Conditions
- Ann Arbor Stage II Mantle Cell Lymphoma
- Ann Arbor Stage III Mantle Cell Lymphoma
- Ann Arbor Stage IV Mantle Cell Lymphoma
Interventions
- PROCEDURE
- DRUG
- BIOLOGICAL
No Results Yet